1. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. (April 2020) Authors: Massias, J S; Smith, E M D; Al-Abadi, E; Armon, K; Bailey, K; Ciurtin, C; Davidson, J; Gardner-Medwin, J; Haslam, K; Hawley, D P; Leahy, A; Leone, V; McErlane, F; Mewar, D; Modgil, G; Moots, R; Pilkington, C; Ramanan, A V; Rangaraj, S; Riley, P Journal: Lupus Issue: Volume 29:Number 5(2020) Page Start: 474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. (April 2019) Authors: Smith, EMD; Al-Abadi, E; Armon, K; Bailey, K; Ciurtin, C; Davidson, J; Gardner-Medwin, J; Haslam, K; Hawley, D; Leahy, A; Leone, V; McErlane, F; Mewar, D; Modgil, G; Moots, R; Pilkington, C; Ramanan, A; Rangaraj, S; Riley, P; Sridhar, A Journal: Lupus Issue: Volume 28:Number 5(2019) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗